This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Incyte Corporation. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2014
Title: Narinder K Chawla-Walia: Innovator in Kinase Research
Introduction
Narinder K Chawla-Walia is a prominent inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of human kinases and phosphatases.
Latest Patents
Narinder holds 3 patents that focus on innovative methods and compositions related to human β-adrenergic receptor kinase. His latest patents include "Antibodies to human β-adrenergic receptor kinase," which provides various embodiments of the invention that include human kinases and phosphatases (KPP) polypeptides and polynucleotides. These embodiments also encompass expression vectors, host cells, antibodies, agonists, and antagonists. Additionally, he has developed methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.
Career Highlights
Narinder is currently associated with Incyte Corporation, where he continues to advance his research in the field. His work has been instrumental in understanding the complexities of human kinases and their implications in various disorders.
Collaborations
Some of his notable coworkers include Vicki S Elliott and Reena Khare, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Narinder K Chawla-Walia's innovative work in kinase research has paved the way for advancements in biotechnology and therapeutic methods. His contributions are vital to the ongoing exploration of human kinases and their potential applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile